A new NIH-backed initiative to speed up personalized cancer vaccine development sent stocks like MRN

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine develo

U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaf

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w

Shares of Novavax, Inc. (NASDAQ: NVAX - Get Free Report) were up 10.5% during mid-day trading on Mon

Novavax (NASDAQ:NVAX) reported second-quarter financial results on Thursday. The transcript from the

In the latest trading session, Novavax (NVAX) closed at $11.27, marking a -10.31% move from the prev

Novavax Inc. (NASDAQ:NVAX) shares are pulling back Tuesday after a more than 20% surge Monday. Vacci

Novavax is pulling back Tuesday after surging more than 20% Monday. Vaccine stocks rallied on a susp

A plague headline out of Siberia lifted vaccine stocks, and the agencies closest to the case have si

Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than averag

Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDA

NVAX, NVDA, MELI, NU, PTC were among the stocks seen trending on Monday, Oct. 5, 2026.

A suspected plague death at a Siberian research institute has investors reaching for the pandemic pl

Unconfirmed plague fears sent Novavax up 24% in a potential short squeeze, lifting vaccine stocks de

Sanofi is carrying the Nuvaxovid COVID-19 shot into the fall vaccination season, and buyers are rewa

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

In the closing of the recent trading day, Novavax (NVAX) stood at $10.79, denoting a +1.53% move fro

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhi

In the most recent trading session, Novavax (NVAX) closed at $10.11, indicating a +1.1% shift from t

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The lat

Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA | MRNA Price Prediction) once aga

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w

In the most recent trading session, Novavax (NVAX) closed at $9.42, indicating a +1.29% shift from t

Novavax NASDAQ: NVAX executives outlined the company's transition from a COVID-19 vaccine-focused bu

Novavax, Inc. (NVAX) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Novavax NASDAQ: NVAX outlined its strategy to expand the use of its Matrix-M adjuvant platform throu

Novavax, Inc. (NVAX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcri

Novavax is rising on investors reaction to an unconfirmed rumor that Matrix-M has a favorable safety

Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as tr

Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine app

U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of A

Novavax, Inc.'s (NASDAQ:NVAX) partners have received approvals for the Nuvaxovid™ formulation to

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligi

Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage

Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on posi

Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinica

https://youtu.be/H_RititNE8U

Novavax (NASDAQ:NVAX) raises FY2026 sales outlook from $230.000 million-$270.000 million to $235.000

Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,

Novavax shares are up on Monday following a licensing agreement with Pfizer for the use of its Matri

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, wi

Retail investors are preparing for another busy week of earnings season with more than 1,600 compani

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease

U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultane